Global knowledge-based CDSS market is expected to reach around $388.5 million by 2018


Posted October 22, 2014 by tonypandrew

The knowledge-based/evidence-based CDSS is used to decrease the rate of medication errors, and increase the quality and efficiency of dispensing medication.

 
The Global Knowledge-based/Evidence-based Clinical Decision Support System (CDSS) market report defines and segments the market globally with analysis and forecast of revenue. The global knowledge-based/evidence-based CDSS market is expected to reach around $388.5 million by 2018, at a CAGR of 8.0% from 2013 to 2018.
Browse through the TOC of the global knowledge-based/evidence-based clinical decision support system (CDSS) market, to get an idea of the in-depth analysis provided. This also provides a glimpse of the market segmentation, and is supported by various tables and figures.

http://www.micromarketmonitor.com/market-report/knowledge-based-evidence-based-cdss-reports-7850360788.html

The knowledge-based/evidence-based CDSS is used to decrease the rate of medication errors, and increase the quality and efficiency of dispensing medication. The hospital information systems are installed on a large-scale in various different regions- North America, Asia, and they include Electronic Health Records (EHR), Computerized Physician Order Entry (CPOE) Systems, Laboratory Information Systems (LIS), Patient Information Sheets (PIS), and diagnostic imaging solutions. These solutions are specifically used to collect, store, and retrieve historical and current data, thereby creating the need for solutions that can analyze large amounts of information and recommend better solutions to patients. To meet this need, the clinical decision support system (CDSS) was introduced as an efficient solution that can offer personalized medicine at the point of care.
The market is expected to grow due to initiatives provided by the Federal government in the U.S., rise in demand of CDSS solutions in order to reduce medical errors and curb healthcare costs, growing medical tourism in the Asian region, and a rise in patient consumerism towards point-of-care. The benefits associated with integrated solutions knowledge-based/evidence-based CDSS are better workflow, elimination of maintenance costs for interfaces between two software, quick retrieval of clinical data, and quick feedback to clinicians.
Geographically, the North American knowledge-based CDSS is contributing the largest share in the global knowledge-based/evidence-based CDSS. To curb the increasing healthcare expenditure is the need of the hour for regions such as North America and Europe. The U.S. is currently facing a major challenge in countering the growing cost of healthcare. Healthcare accounted for 17.6% of the GDP in 2010, and this figure is estimated to reach 26% by 2035 (highest across the globe). The growing cost of healthcare has pressurized the healthcare industry to provide optimum solutions. Therefore, governments of various countries are taking a favorable step towards setting up the Agency for Healthcare Research and Quality (AHRQ), with an objective to provide support for developing, implementing, and evaluating the use of health information technology to improve the healthcare decision making process, to reduce medical errors ,and to support the growth of this market to a large extent.
Some favorable initiatives by the European Commission such as eGovernment Action Plan 2011-2015 will help to encourage the healthcare IT systems such as CDSS in the region. The eEurope Action Plan covers online health plans, health cards, and health information networks to foster the development of healthcare IT solutions among citizens, which in turn is likely to affect the knowledge-based/ evidence-based CDSS market.
The Asian healthcare industry too is undergoing transformation from paper-based to a digitized system. The major factors influencing this trend are the consumer-driven healthcare system, rise in the number of outpatient visits, cost of treating chronic diseases, increasing disposable incomes, and affordable healthcare services. Governments across the region have kept an efficient, affordable, and on-time delivery of quality care as top priority. As a result, a paradigm shift is noticed, which has transformed acute care to point-of-care. Besides, IT solutions are implemented, mainly EHR with CDSS and CPOE capability. The countries actively adopting integrated CDSS solutions are Japan, China, India, and South Korea. The Indian CDSS market is still at a nascent stage, whereas Japan, China, and South Korea are lucrative markets for investors.
Key players offering knowledge-based/evidence-based support globally are Zynx Health (Los Angeles), Wolters Kluwer (Netherlands), and Thomson Reuters (U.S.)
This market is segmented and forecast on the basis of components and deployments of global knowledge-based/evidence-based CDSS market. On the basis of products, the market is divided as integrated and standalone knowledge-based/evidence based CDSS market. The components comprise hardware, software, and services, and the deployments are on-premise, cloud-based, and web-based. The market is further segmented and forecast on the basis of major geographic regions such as North America, Europe, Asia, and RoW. The market is also segmented and analyzed further on the basis of the major applications and end-users.
This report also includes the market share, value chain analyses, and market metrics such as drivers, restraints, and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of key players in the market including major companies of the market.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By micromarketmonitor
Country United States
Categories Health
Tags knowledgebased clinical decision support system market
Last Updated October 22, 2014